Funding a Shareholder Agreement With Life Insurance
The agreement is signed, filed, and forgotten. Everyone assumes the hard part is done. The hard part was never the wording.
A shareholder agreement says what happens when an owner dies, leaves, or can no longer work. It says buy the shares. What it rarely says is where the money comes from. Life insurance is one commonly used answer: it puts the cash in place before the trigger arrives, so the buyout the agreement promises can actually be paid.
- A buy-sell agreement is a promise to buy shares. The funding is whether that promise can be kept. Unfunded, it’s a bill with no account behind it.
- There are three main funding methods, criss-cross, corporate redemption, and promissory note, and they produce different tax outcomes for the survivors and the estate.
- The promissory-note method can combine characteristics of both: corporate funding of the premiums and a cost-base increase for the surviving shareholders. Its tax result depends on the agreement, the policy ownership, the share structure, and the post-death transactions.
- The most common failure isn’t the wrong method. It’s coverage set to an old valuation, so the funding no longer matches what the shares are worth.
The gap between the agreement and the money
The agreement gets drafted, signed, and filed. Everyone treats the hard part as done. But the wording was never the hard part. The hard part is the money behind it, and that’s the part most agreements leave unaddressed.
Picture two owners of a company worth four million dollars. The agreement says that if one dies, the survivor buys the deceased’s half. One dies. Now the survivor owes two million dollars to a grieving family, and the only place to get it is the business itself, drained or borrowed against at the worst possible moment. The family, meanwhile, holds shares in a company they don’t run and may not be able to sell. An agreement without funding didn’t prevent that situation. It scheduled it.
How life insurance closes the gap
Life insurance on each shareholder puts the purchase money in place ahead of the event. When an owner dies, the death benefit provides the cash to buy their shares at the agreed price, so the survivors keep control of the company and the family receives full value in cash rather than an illiquid minority stake. The agreement and the policy are two halves of one mechanism. Neither works without the other.
How the money moves, and how it’s taxed, depends on which of three funding methods the agreement uses. They look similar on the surface and diverge sharply in their tax results.
The three funding methods
They differ in who owns the policy, who buys the shares, and how the tax lands.
Which method fits depends on the corporate structure, the number of shareholders, the tax positions involved, and how the owners want the shares to move. The corporate-owned methods bring the capital dividend account into play, which is a significant advantage and a significant place to make an error. This is chosen with the accountant and the lawyer together, because the agreement’s wording and the policy’s ownership have to describe the same plan.
The stop-loss trap in corporate redemptions
When a corporation redeems a deceased shareholder’s shares using a tax-free capital dividend, a set of rules known as the stop-loss rules can limit a capital loss the estate would otherwise use to offset the gain triggered at death. Left unaddressed, that can mean the estate pays more tax than expected. Planners work around it with structures known by shorthand names, the fifty-percent solution, the hybrid, roll-and-redeem, each balancing the capital dividend account benefit against the loss the estate needs. The detail belongs to the tax advisor. The point for an owner is that a corporate redemption is not simply the corporate version of a buyout. It carries its own tax mechanics that have to be planned for.
The failure that actually happens: stale funding
In practice, most buy-sell problems aren’t caused by choosing the wrong method. They’re caused by funding that stopped matching the business. A company insured to a valuation from six years ago, now worth twice as much, is half-funded. When the trigger comes, the insurance covers half the buyout and the survivors have to find the rest, which is the exact problem the agreement was supposed to solve.
Two things prevent it. The agreement should specify how the shares are valued and how often that valuation is refreshed. And the coverage should be reviewed on the same schedule, with the option to increase it as the business grows built in from the start. A buy-sell isn’t a document you sign once. It’s a mechanism you maintain.
When funding a shareholder agreement with insurance fits, and when it doesn’t
There is more than one shareholder, the agreement obligates a buyout on death or departure, and the shares represent real value the survivors couldn’t easily fund from cash on hand. Which is nearly every private company with partners and a growing balance sheet.
A sole owner with no co-shareholders has no buy-sell to fund, though estate liquidity may still matter. Or the owners have deliberately set aside enough liquid capital to fund a buyout without insurance. And a shareholder in poor health may not be insurable, in which case the agreement needs a different funding plan.
Common questions
Does every shareholder agreement need insurance?
If the agreement obligates the surviving owners or the corporation to buy a deceased shareholder’s shares, it needs a funding source, and insurance is one commonly used option, alongside cash reserves, borrowing, or an installment purchase. An agreement that promises a buyout without funding is a bill with no account behind it. When the trigger arrives, the survivors either drain the business, borrow at the worst possible time, or renegotiate with a grieving family. Insurance puts the cash in place before it’s needed. The exception is where owners have deliberately set aside sufficient liquid capital for the obligation.
Who should own the policies?
It depends on the funding method. In a criss-cross arrangement each shareholder personally owns a policy on the others, paying premiums with personal after-tax dollars. In the corporate-owned methods (redemption or promissory note), the corporation owns the policies and pays with corporate income that may be taxed at a lower rate than funds distributed personally, depending on the corporation and method of remuneration, and the death benefit can feed the capital dividend account. The ownership choice drives the tax outcome, so it’s decided together with the accountant and lawyer, not settled by default. The wrong ownership can forfeit tax advantages the agreement was meant to capture.
How much insurance is needed?
Enough to fund each shareholder’s share of the business value at the price the agreement sets. That means the coverage has to track a current valuation, using the valuation formula written into the shareholder agreement. The common failure is coverage set to an old number: a company that has doubled in value since the policies were bought is now half-funded, and the gap surfaces exactly when it can’t be fixed. Coverage should be reviewed as the business grows, not set once and forgotten.
What happens when the company value increases?
The funding gap widens unless the coverage is updated. A buy-sell funded to a valuation from several years and one growth cycle ago no longer matches what the shares are worth, so the insurance pays only part of the buyout and the survivors have to find the rest. This is why the agreement should specify how the shares are valued and how often, and why the insurance should be reviewed on the same schedule. Some policies are structured to allow coverage increases as the business grows, which is worth building in from the start.
Can the company pay the premiums?
Yes, in the corporate-owned funding methods. When the corporation owns the policies, it pays the premiums with corporate income that may be taxed at a lower rate than the personal income each shareholder would otherwise draw in a criss-cross arrangement, depending on the corporation and method of remuneration, which can mean less pre-tax income is required. This also evens out cost differences between shareholders of different ages and health. The trade-off is that corporate ownership brings the capital dividend account, stop-loss rules, and creditor considerations into play, which is why the method is chosen deliberately rather than for the premium saving alone.
Are the premiums deductible?
Generally no, whether the policy is owned personally or by the corporation. Life insurance premiums are paid with after-tax dollars in almost all buy-sell structures. The corporate advantage isn’t a deduction; it’s that premiums can be funded with corporate income that may be taxed at a lower rate than funds distributed personally, depending on the corporation and method of remuneration, so less pre-tax income is required, and that eligible proceeds may support a capital dividend, subject to the corporation’s actual CDA balance and a valid election. The one narrow exception to non-deductibility is a policy collaterally assigned for a business loan, which is not the usual buy-sell situation.
Can one policy fund several obligations?
It can, but stacking obligations on one policy is where structures go wrong. A single corporate-owned policy might be intended to fund a buyout, provide key-person coverage, and create estate liquidity all at once. Each of those has a different owner, beneficiary, and tax treatment that works best, and combining them can compromise all three. It’s usually cleaner to match coverage to purpose. Where a policy genuinely serves more than one goal, the structure needs to be designed for it deliberately, with the accountant confirming the tax result.
What if a shareholder becomes disabled instead of dying?
A well-drafted shareholder agreement addresses disability and long-term illness as buy-sell triggers, not just death, because a shareholder who can no longer work but hasn’t died creates the same ownership problem without the life insurance payout. Funding for the disability trigger is a separate question, sometimes met with disability buy-out insurance, sometimes with a structured payout over time. The point is that death is only one of the events an agreement should anticipate, and the funding has to match the triggers the agreement actually contains.
- Income Tax Act, subsection 89(1) (capital dividend account), subsection 83(2) (capital dividend election), and the stop-loss rules applicable to share redemptions.
- Insurer advanced-markets technical material on buy-sell funding methods (criss-cross, corporate redemption, promissory note, and hybrid), for the mechanics compared here.
- Income Tax Act, subsection 70(5) (deemed disposition of shares at death), relevant to the estate’s capital gain and cost-base treatment.
This material is provided for general educational purposes and is not individualized legal, tax, accounting, investment or insurance advice. The examples and strategies discussed may not be appropriate in every circumstance. Tax and legal outcomes depend on individual facts, ownership, policy terms and legislation in effect at the relevant time, and may change. Insurance recommendations should be based on an individual needs analysis and consideration of available alternatives, product terms, costs, guarantees and risks. Where tax, accounting or legal matters are involved, Sheldrake Group works alongside the client’s qualified professional advisers.